Globus Medical Statistics Share Statistics Globus Medical has 135.41M
shares outstanding. The number of shares has increased by -0.02%
in one year.
Shares Outstanding 135.41M Shares Change (YoY) -0.02% Shares Change (QoQ) -15.37% Owned by Institutions (%) 79.24% Shares Floating 134.41M Failed to Deliver (FTD) Shares 3 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 4.52M, so 3.34% of the outstanding
shares have been sold short.
Short Interest 4.52M Short % of Shares Out 3.34% Short % of Float 4.48% Short Ratio (days to cover) 2.58
Valuation Ratios The PE ratio is 109.01 and the forward
PE ratio is 16.25.
Globus Medical's PEG ratio is
-3.6.
PE Ratio 109.01 Forward PE 16.25 PS Ratio 4.46 Forward PS 2.6 PB Ratio 2.69 P/FCF Ratio 27.7 PEG Ratio -3.6
Financial Ratio History Enterprise Valuation Globus Medical has an Enterprise Value (EV) of 10.98B.
EV / Sales 4.36 EV / EBITDA 28.97 EV / EBIT 21.09 EV / FCF 27.09
Financial Position The company has a current ratio of 2.54,
with a Debt / Equity ratio of 0.13.
Current Ratio 2.54 Quick Ratio 1.77 Debt / Equity 0.13 Debt / EBITDA 1.42 Debt / FCF 1.33 Interest Coverage 39.63
Financial Efficiency Return on Equity is 2.47% and Return on Invested Capital is 2.92%.
Return on Equity 2.47% Return on Assets 1.96% Return on Invested Capital 2.92% Revenue Per Employee $475.35K Profits Per Employee $19.43K Employee Count 5,300 Asset Turnover 0.48 Inventory Turnover 1.57
Taxes Income Tax 17.74M Effective Tax Rate 14.69%
Stock Price Statistics The stock price has increased by -18.62% in the
last 52 weeks. The beta is 1.2, so Globus Medical's
price volatility has been higher than the market average.
Beta 1.2 52-Week Price Change -18.62% 50-Day Moving Average 57.12 200-Day Moving Average 72.84 Relative Strength Index (RSI) 61.08 Average Volume (20 Days) 1,542,979
Income Statement In the last 12 months, Globus Medical had revenue of 2.52B
and earned 102.98M
in profits. Earnings per share was 0.76.
Revenue 2.52B Gross Profit 1.48B Operating Income 165.99M Net Income 102.98M EBITDA 378.94M EBIT 219.7M Earnings Per Share (EPS) 0.76
Full Income Statement Balance Sheet The company has 784.44M in cash and 537.19M in
debt, giving a net cash position of 247.25M.
Cash & Cash Equivalents 784.44M Total Debt 537.19M Net Cash 247.25M Retained Earnings 1.15B Total Assets 4.71B Working Capital 1.33B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 520.64M
and capital expenditures -115.43M, giving a free cash flow of 405.21M.
Operating Cash Flow 520.64M Capital Expenditures -115.43M Free Cash Flow 405.21M FCF Per Share 2.99
Full Cash Flow Statement Margins Gross margin is 58.9%, with operating and profit margins of 6.59% and 4.09%.
Gross Margin 58.9% Operating Margin 6.59% Pretax Margin 4.79% Profit Margin 4.09% EBITDA Margin 15.04% EBIT Margin 6.59% FCF Margin 16.08%
